Wang, L.; Shui, X.; Mei, Y.; Xia, Y.; Lan, G.; Hu, L.; Zhang, M.; Gan, C.-L.; Li, R.; Tian, Y.;
et al. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease. Int. J. Mol. Sci. 2022, 23, 7992.
https://doi.org/10.3390/ijms23147992
AMA Style
Wang L, Shui X, Mei Y, Xia Y, Lan G, Hu L, Zhang M, Gan C-L, Li R, Tian Y,
et al. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease. International Journal of Molecular Sciences. 2022; 23(14):7992.
https://doi.org/10.3390/ijms23147992
Chicago/Turabian Style
Wang, Long, Xindong Shui, Yingxue Mei, Yongfang Xia, Guihua Lan, Li Hu, Mi Zhang, Chen-Ling Gan, Ruomeng Li, Yuan Tian,
and et al. 2022. "miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease" International Journal of Molecular Sciences 23, no. 14: 7992.
https://doi.org/10.3390/ijms23147992
APA Style
Wang, L., Shui, X., Mei, Y., Xia, Y., Lan, G., Hu, L., Zhang, M., Gan, C.-L., Li, R., Tian, Y., Wang, Q., Gu, X., Chen, D., Zhang, T., & Lee, T. H.
(2022). miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease. International Journal of Molecular Sciences, 23(14), 7992.
https://doi.org/10.3390/ijms23147992
